NASDAQ:ADVM - Adverum Biotechnologies, Inc.
$14.17
 $0.20
+1.43%
4:00PM EDT
2019-07-22
Adverum Biotechnologies, Inc., formerly Avalanche Biotechnologies, Inc., is a gene therapy company. The Company is engaged in discovering and developing medicines to patients suffering from chronic or debilitating disease. The Company operates and manages its business in the segment of developing and commercializing gene therapeutics. It focuses on diseases with unmet medical need, including ophthalmic diseases, such as wet age-related macular degeneration (AMD), as well as rare genetic diseases. The Company's product candidates include AVA-101 and AVA-201 for treatment of Wet AMD; AVA-322 and AVA-323 for the treatment of Color Vision Deficiency, and AVA-311 for the treatment of Juvenile X-linked Retinoschisis. It has generated human proof-of-concept data for AVA-101 in a Phase I trial with over eight wet AMD subjects conducted at Lions Eye Institute (LEI) in Australia. It is developing AVA-322 and AVA-323 for the treatment of color vision deficiency (CVD). Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  ADVM     avg for
industry  
  avg for
sector  
42 stocks weight:  42. 69   217. 37   399. 45  
42 stocks rank:  2. 54 K 1. 27 K 716. 99  
# analyst opinions:  4. 00   13. 21   13. 71  
mean recommendation:  2. 60   2. 10   2. 04  

quick ratio:  17. 86   5. 49   1. 88  
current ratio:  18. 20   5. 87   2. 36  

target price low:  3. 00   83. 44   114. 90  
target price avg:  5. 88   106. 20   137. 90  
target price high:  12. 00   132. 30   158. 97  
1-yr high:  15. 89   111. 86   142. 57  
last close:  13. 97   86. 79   125. 44  
50-day avg:  11. 09   86. 68   122. 63  
200-day avg:  6. 08   89. 22   121. 38  
1-yr low:  2. 87   69. 78   100. 51  
volume:  1. 06 M 2. 62 M 3. 43 M
50-day avg volume:  1. 07 M 3. 20 M 4. 16 M
200-day avg volume:  650. 93 K 2. 99 M 4. 75 M

1-day return:  1. 45 % -1. 30 % -0. 99 %
this week return:  -6. 68 % 0. 45 % -0. 20 %
12-wk return:  107. 58 % 0. 94 % 4. 84 %
52-wk return:  170. 00 % -1. 30 % 10. 55 %

enterprise value (EV):  722. 60 M 45. 10 B 122. 38 B
market cap:  891. 02 M 38. 96 B 108. 40 B
EBITDA:  -63. 33 M 4. 20 B 8. 19 B
enterprise multiple (EV/EBITDA):  -11. 41   5. 38   11. 93  
enterprise/revenue (EV/R):  517. 62   57. 92   10. 21  
total revenue:  1. 40 M 9. 91 B 39. 98 B
total debt:  25. 90 M 10. 90 B 17. 48 B
debt/equity:  13. 77   57. 18   120. 05  
net income (common):  -69. 92 M 2. 07 B 4. 05 B

shares outstanding:  0. 00   538. 09 M 1. 24 B
shares:  34. 73 M 548. 00 M 1. 22 B
shares short:  6. 49 M 10. 98 M 11. 87 M
shares short prior month:  4. 59 M 9. 32 M 12. 05 M
short ratio:  7. 03   5. 60   3. 34  
short % of float:  11. 67 % 6. 48 % 2. 64 %
total cash/share:  2. 99   10. 98   9. 19  
total cash:  189. 49 M 5. 93 B 6. 10 B
free cash flow:  -33. 39 M 2. 92 B 4. 55 B
operating cash flow:  -54. 20 M 3. 80 B 5. 78 B

book value:  2. 97   13. 35   27. 45  
price/book:  4. 70   4. 60   8. 78  
gross profits:  -48. 52 M 7. 44 B 36. 13 B
operating margins:  -4659. 17 % -308. 40 % -28. 55 %
EBITDA margins:  0. 00 % 13. 17 % 23. 38 %
profit margins:  0. 00 % 10. 44 % 14. 18 %
gross margins:  0. 00 % 35. 80 % 55. 40 %

1-yr max volatility:  0. 00 % --- ---
1-yr mean volatility:  0. 00 % 1. 66 % 1. 03 %

1-yr EPS:  -1. 11   2. 10   4. 23  
forward EPS:  -1. 13   3. 45   7. 10  
P/E:  -12. 55   1. 90   32. 10  
forward P/E:  -12. 36   6. 46   15. 47  
PE/G:  3. 02   0. 70   -0. 54  
growth:  -4. 16 % 265. 63 % 79. 11 %
earnings high:  -0. 24   0. 89   1. 68  
earnings avg:  -0. 29   0. 70   1. 57  
earnings low:  -0. 41   0. 46   1. 46  
revenue high:  460. 00 K 2. 57 B 11. 07 B
revenue avg:  300. 00 K 2. 51 B 10. 91 B
revenue low:  -0. 00   2. 45 B 10. 73 B
return on assets:  -17. 00 % -2. 34 % 5. 28 %
return on equity:  -32. 21 % -90. 08 % 133. 53 %
revenue/share:  0. 02   12. 72   60. 04  

beta (1yr vs S&P500):  1. 53   1. 27   0. 91  
sharpe (1yr):  1. 67   0. 16   0. 77  

held % insiders:  11. 22 % 6. 06 % 3. 29 %
held % institutions:  73. 40 % 78. 22 % 69. 37 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-21 : ADVM
.    118.902 =       118.902 :: --> INITIAL WEIGHT <--
.    - 1.113 =       117.789 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 2.326 =       273.988 :: P/E factor
.    x 0.912 =       249.956 :: PE/G factor
.    x 1.541 =       385.237 :: beta factor
.    x 1.666 =       641.967 :: sharpe factor
.    x 3.122 =      2004.269 :: current ratio factor
.    x 1.029 =      2062.855 :: quick ratio factor
.    x 1.069 =      2204.696 :: short ratio factor
.    x 3.142 =      6926.257 :: EV/R factor
.    x 1.058 =      7328.701 :: price-to-book factor
.    x 0.656 =      4809.114 :: debt-to-revenue factor
.    x 1.114 =      5356.875 :: debt-to-equity factor
.                               --> PERFORMANCE <--
.    x 2.121 =     11360.824 :: sector+industry 1-year gains factor
.    x 1.009 =     11467.935 :: industry 12-weeks return factor
.    x 1.308 =     14998.781 :: industry 2-weeks return factor
.    x 2.713 =     40686.013 :: company one-year gains+dividend factor
.    x 3.669 =    149266.957 :: company 13 weeks' performance factor
.    x 3.899 =     582060.12 :: 5-day avg > 200-day avg
.    x 2.438 =   1419110.396 :: 5-day avg > 50-day avg
.    x 1.825 =    2589715.46 :: 50-day avg > 200-day avg
.     x 0.95 =    2461077.72 :: "drift" penalty 4 days ago
.    / 2.117 =   1162571.754 :: overall "drift" factor
.     x 0.56 =    651037.425 :: largest single-day jump factor
.    x 0.312 =    202815.397 :: low price factor
.      x 1.4 =    283881.606 :: notable returns + performance factor
.     x 2.19 =     621791.87 :: inverse volume-to-price factor
.                               --> PROJECTIONS <--
.    x 0.962 =    598066.733 :: forward EPS factor
.    x 0.986 =    589774.441 :: forward P/E factor
.    x 1.185 =    698713.152 :: industry recommendation factor
.    x 1.743 =   1218001.941 :: company recommendation factor
.    x 1.003 =   1221370.184 :: factor historical industry gain for week 29
.    x 0.865 =   1056188.075 :: target low factor
.    x 0.897 =    947477.237 :: target mean factor
.    x 0.989 =    936589.725 :: target high factor
.    x 0.856 =    801711.827 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =        29.923 :: reduced for readability
.   + 11.727 =         41.65 :: add/subtract for investor sentiment
.    + 1.037 =        42.687 :: earnings report in 16 days
.                               --> FINAL WEIGHT <--
.                     42.687 :: FINAL WEIGHT for NASDAQ:ADVM


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org